uniQure (QURE)
(Delayed Data from NSDQ)
$4.91 USD
+0.03 (0.61%)
Updated May 14, 2024 04:00 PM ET
After-Market: $4.91 0.00 (0.00%) 6:44 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
uniQure N.V. [QURE]
Reports for Purchase
Showing records 21 - 40 ( 153 total )
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Pipeline Programs Progressing With Multiple Near- Term Potential Positive Events Expected; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
2Q21 Results; Progress on Multiple Fronts; Potential Positive Events on EtranaDez and AMT-130 on Deck
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Upbeat R&D Day Event Highlights Key Hem-B and Huntington''s Programs, Broad CNS Pipeline Expansion; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Updating Hemophilia B Assumptions Following Plethora of Good News; Upping PT to $90; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
FDA Clinical Hold on Hem-B Program Lifted; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Positive Outcome in HCC Investigation Foreshadows Potential Lift of Clinical Hold on Hem-B Program
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Well-Positioned Ahead of Several Significant Events in 2021; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
AMT-130 Clears Safety Hurdle in Huntington''s Program; Biomarker and Imaging Data Expected By End of 2021; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
False Start; Clinical Hold Announced on EtranaDez; Lowering Price Target to $80; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
To Bleed or Not To Bleed, That Is the $40B Question for Novel Hem-B Nonfactor Replacement Treatments
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
EtranaDez Looking Like the Leader in Hem-B; Raising Price Target to $85; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Transferring Coverage With a Buy and $80 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Does the Buck Stop at the Two Year Annualized Bleeding Rate
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
2Q20 Update: Post-Licensing Drawdown Offers a Compelling Entry Point
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
How Far We''ve Come, How Little We Know
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Hem-B Commercial Risk Diversification; But the Street Likely to Sing a Different Tune
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Countdown to HD Gene Silencing Data Activated
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
A Quiet Mid-Year, But Set Up for a Big Finish
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Market Shudders But We See Names to Outperform.
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department